MDT 69.06 Medtronic Inc $MDT Hit a 52 week high of
Post# of 88940
Posted On: 11/14/2014 1:31:04 PM
MDT 69.06 Medtronic Inc $MDT Hit a 52 week high of 69.46 Closing the day 09:45 at 69.06 -0.32 -0.46% With a day low of 69.02 and a total volume of 240,858.
MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Midday Glance: Medical Devices companies
AP - 12 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 109.90 (-0.71), JNJ: 108.25 (-0.82), MDT: 68.88 (-0.50), BAX: 71.69 (-0.39)
Early Glance: Medical Devices companies
AP - 2 hrs 42 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 109.90 (-0.71), JNJ: 108.25 (-0.82), MDT: 68.88 (-0.50), BAX: 71.69 (-0.39)
Is Medtronic (MDT) Poised to Beat Q2 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 49 mins ago
Medtronic Inc. (MDT) is scheduled to report its second-quarter fiscal 2015 earnings before the opening bell on Nov 18.
KR: 57.85 (-0.54), MDT: 68.88 (-0.50), WSM: 69.54 (+1.15), ROST: 81.48 (-1.08)
Xerox (XRX) Forays into Telemedicine with HealthSpot Stake - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 5:10PM CST
Xerox (XRX) announced that it has invested an undisclosed amount in HealthSpot, a Dublin-based telemedicine provider that sets up kiosks to connect patients with physicians.
MDT: 68.88 (-0.50), GOOGL: 554.49 (-1.95), XRX: 13.56 (+0.11), RAD: 5.47 (+0.08)
Final Glance: Medical Devices companies
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 109.90 (-0.71), JNJ: 108.26 (-0.81), MDT: 68.88 (-0.50), BAX: 71.69 (-0.39)
Watch for Medtronic to Potentially Pullback After Gaining 1.28% Yesterday
Comtex SmarTrend(R) - Thu Nov 13, 3:55PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.66 to a high of $69.62. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $69.33 on volume of 6.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.88 (-0.50)
Look for Shares of Medtronic to Potentially Pullback after Yesterday's 1.28% Rise
Comtex SmarTrend(R) - Thu Nov 13, 3:55PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.66 to a high of $69.62. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $69.33 on volume of 6.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.88 (-0.50)
Medtronic Study Reveals Significant Heart Rhythm Disorders Occurring in Patients Undergoing Hemodialysis
Thomson Reuters ONE - Thu Nov 13, 3:30PM CST
Data Presented at Kidney Week 2014 Find Irregular Heartbeats
MDT: 68.88 (-0.50)
Agilent 2.0: Phase 2 Of Corporate Action?
AtonRa Partners - at Seeking Alpha - Thu Nov 13, 12:20PM CST
MDT: 68.88 (-0.50), A: 41.54 (+0.09), TMO: 118.59 (+0.35), DHR: 82.15 (-0.25)
Global Insulin Delivery Devices Market Outlook 2018
M2 - Thu Nov 13, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/ttg7ws/global_insulin) has announced the addition of the "Global Insulin Delivery Devices Market Outlook 2018" report to their offering. In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million. This finding by the International Diabetes Federation (IDF) and similar results from studies done by organizations of repute such as WHO, CDC, NHS, etc., suggest that a huge patient population exists in the diabetes market. In 2013, health expenditure on diabetes accounted for around 10% of the total health expenditure globally. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study. In this latest research study Global Insulin Delivery Devices Market Outlook 2018, the analysts identified the market dynamics in various important regions to highlight the areas offering promising opportunities to companies for boosting their growth. Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of the delivery devices market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth, and the future outlook of the segments. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Global Insulin Market Overview to 2018 4. Industry Trends and Drivers 5. Key Market Restraints 6. Global Insulin Delivery Devices Market Outlook to 2018 7. Insulin Delivery Devices: Current and Future Outlook to 2018 8. Emerging Devices 9. Key Players Companies Mentioned: - Abbott Laboratories - B. Braun Melsungen AG - Becton Dickinson - Eli Lilly - F. Hoffmann La Roche - Insulet Corporation - Johnson and Johnson - Medtronic - Novo Nordisk - Sanofi-Aventis - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/tt...al_insulin
JNJ: 108.26 (-0.81), ABT: 43.85 (-0.74), PODD: 45.23 (-0.58), NVO: 44.02 (unch), MDT: 68.88 (-0.50), LLY: 67.30 (-0.38)
Neurostimulation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020
M2 - Thu Nov 13, 2:52AM CST
Industry Insights
BSX: 13.35 (-0.06), MDT: 68.88 (-0.50), CYBX: 52.34 (+1.03)
Medtronic Adds to Endurant 'AAA' Stent Graft System
Thomson Reuters ONE - Wed Nov 12, 2:00PM CST
New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic Aneurysms
MDT: 68.88 (-0.50)
Medtronic and St. Jude Medical Dominate the European Pain Management Device Market
PR Newswire - Wed Nov 12, 11:00AM CST
Decision Resources Group finds that the European pain management device market generates a majority of revenue from select products, such as spinal cord stimulation (SCS) and radiofrequency (RF) ablation devices. This results in key players like Medtronic and St. Jude Medical capturing significant share. Increasing recognition of the value of pain management devices over pharmaceuticals will, however, drive moderate market growth, leading to increased competition as manufacturers shift focus to the device market.
MDT: 68.88 (-0.50)
Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 33.31 (-0.39), MDT: 68.88 (-0.50), GMED: 22.69 (-0.23)
Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 33.31 (-0.39), MDT: 68.88 (-0.50), GMED: 22.69 (-0.23)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 134.03 (+2.13), MDT: 68.88 (-0.50), C: 53.37 (-0.07), WMT: 82.58 (-0.36), RBS: 11.80 (+0.05), UBS: 17.55 (+0.01), NOK: 7.84 (-0.42), YHOO: 51.76 (+1.26), PBR: 9.84 (-0.36), SPY: 204.10 (-0.09), SAP: 66.77 (+0.14), EBAY: 54.33 (-0.04), JPM: 60.40 (+0.17), BHP: 57.93 (+0.30), AAPL: 113.96 (+1.14), BCS: 14.57 (+0.14), FRM: 6.10 (-0.16), COV: 93.45 (-0.22), HSBC: 50.24 (+0.09), FRGI: 57.40 (+0.97), ZTS: 43.17 (-0.07), DLA: 10.50 (+0.05), QQQ: 103.13 (+0.23), AOL: 46.18 (-0.19), BABA: 115.05 (+0.21)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 68.89 (-0.49), COV: 93.45 (-0.22)
MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Midday Glance: Medical Devices companies
AP - 12 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 109.90 (-0.71), JNJ: 108.25 (-0.82), MDT: 68.88 (-0.50), BAX: 71.69 (-0.39)
Early Glance: Medical Devices companies
AP - 2 hrs 42 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 109.90 (-0.71), JNJ: 108.25 (-0.82), MDT: 68.88 (-0.50), BAX: 71.69 (-0.39)
Is Medtronic (MDT) Poised to Beat Q2 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 49 mins ago
Medtronic Inc. (MDT) is scheduled to report its second-quarter fiscal 2015 earnings before the opening bell on Nov 18.
KR: 57.85 (-0.54), MDT: 68.88 (-0.50), WSM: 69.54 (+1.15), ROST: 81.48 (-1.08)
Xerox (XRX) Forays into Telemedicine with HealthSpot Stake - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 5:10PM CST
Xerox (XRX) announced that it has invested an undisclosed amount in HealthSpot, a Dublin-based telemedicine provider that sets up kiosks to connect patients with physicians.
MDT: 68.88 (-0.50), GOOGL: 554.49 (-1.95), XRX: 13.56 (+0.11), RAD: 5.47 (+0.08)
Final Glance: Medical Devices companies
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 109.90 (-0.71), JNJ: 108.26 (-0.81), MDT: 68.88 (-0.50), BAX: 71.69 (-0.39)
Watch for Medtronic to Potentially Pullback After Gaining 1.28% Yesterday
Comtex SmarTrend(R) - Thu Nov 13, 3:55PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.66 to a high of $69.62. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $69.33 on volume of 6.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.88 (-0.50)
Look for Shares of Medtronic to Potentially Pullback after Yesterday's 1.28% Rise
Comtex SmarTrend(R) - Thu Nov 13, 3:55PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.66 to a high of $69.62. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $69.33 on volume of 6.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.88 (-0.50)
Medtronic Study Reveals Significant Heart Rhythm Disorders Occurring in Patients Undergoing Hemodialysis
Thomson Reuters ONE - Thu Nov 13, 3:30PM CST
Data Presented at Kidney Week 2014 Find Irregular Heartbeats
MDT: 68.88 (-0.50)
Agilent 2.0: Phase 2 Of Corporate Action?
AtonRa Partners - at Seeking Alpha - Thu Nov 13, 12:20PM CST
MDT: 68.88 (-0.50), A: 41.54 (+0.09), TMO: 118.59 (+0.35), DHR: 82.15 (-0.25)
Global Insulin Delivery Devices Market Outlook 2018
M2 - Thu Nov 13, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/ttg7ws/global_insulin) has announced the addition of the "Global Insulin Delivery Devices Market Outlook 2018" report to their offering. In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million. This finding by the International Diabetes Federation (IDF) and similar results from studies done by organizations of repute such as WHO, CDC, NHS, etc., suggest that a huge patient population exists in the diabetes market. In 2013, health expenditure on diabetes accounted for around 10% of the total health expenditure globally. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study. In this latest research study Global Insulin Delivery Devices Market Outlook 2018, the analysts identified the market dynamics in various important regions to highlight the areas offering promising opportunities to companies for boosting their growth. Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of the delivery devices market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth, and the future outlook of the segments. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Global Insulin Market Overview to 2018 4. Industry Trends and Drivers 5. Key Market Restraints 6. Global Insulin Delivery Devices Market Outlook to 2018 7. Insulin Delivery Devices: Current and Future Outlook to 2018 8. Emerging Devices 9. Key Players Companies Mentioned: - Abbott Laboratories - B. Braun Melsungen AG - Becton Dickinson - Eli Lilly - F. Hoffmann La Roche - Insulet Corporation - Johnson and Johnson - Medtronic - Novo Nordisk - Sanofi-Aventis - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/tt...al_insulin
JNJ: 108.26 (-0.81), ABT: 43.85 (-0.74), PODD: 45.23 (-0.58), NVO: 44.02 (unch), MDT: 68.88 (-0.50), LLY: 67.30 (-0.38)
Neurostimulation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020
M2 - Thu Nov 13, 2:52AM CST
Industry Insights
BSX: 13.35 (-0.06), MDT: 68.88 (-0.50), CYBX: 52.34 (+1.03)
Medtronic Adds to Endurant 'AAA' Stent Graft System
Thomson Reuters ONE - Wed Nov 12, 2:00PM CST
New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic Aneurysms
MDT: 68.88 (-0.50)
Medtronic and St. Jude Medical Dominate the European Pain Management Device Market
PR Newswire - Wed Nov 12, 11:00AM CST
Decision Resources Group finds that the European pain management device market generates a majority of revenue from select products, such as spinal cord stimulation (SCS) and radiofrequency (RF) ablation devices. This results in key players like Medtronic and St. Jude Medical capturing significant share. Increasing recognition of the value of pain management devices over pharmaceuticals will, however, drive moderate market growth, leading to increased competition as manufacturers shift focus to the device market.
MDT: 68.88 (-0.50)
Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 33.31 (-0.39), MDT: 68.88 (-0.50), GMED: 22.69 (-0.23)
Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 33.31 (-0.39), MDT: 68.88 (-0.50), GMED: 22.69 (-0.23)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 134.03 (+2.13), MDT: 68.88 (-0.50), C: 53.37 (-0.07), WMT: 82.58 (-0.36), RBS: 11.80 (+0.05), UBS: 17.55 (+0.01), NOK: 7.84 (-0.42), YHOO: 51.76 (+1.26), PBR: 9.84 (-0.36), SPY: 204.10 (-0.09), SAP: 66.77 (+0.14), EBAY: 54.33 (-0.04), JPM: 60.40 (+0.17), BHP: 57.93 (+0.30), AAPL: 113.96 (+1.14), BCS: 14.57 (+0.14), FRM: 6.10 (-0.16), COV: 93.45 (-0.22), HSBC: 50.24 (+0.09), FRGI: 57.40 (+0.97), ZTS: 43.17 (-0.07), DLA: 10.50 (+0.05), QQQ: 103.13 (+0.23), AOL: 46.18 (-0.19), BABA: 115.05 (+0.21)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 68.89 (-0.49), COV: 93.45 (-0.22)
(0)
(0)Scroll down for more posts ▼